Theranexus (EPA:ALTHX) | WebDisclosure

BRIEF

published on 09/26/2024 at 18:05, 1 year 4 months ago

Theranexus annonce ses résultats financiers du premier semestre 2024

Résultats Financiers Biopharmaceutique Réduction Des Coûts Theranexus Batten-1
BRIEF

published on 09/26/2024 at 18:05, 1 year 4 months ago

Theranexus announces its financial results for the first half of 2024

Financial Results Cost Reduction Biopharmaceutical Theranexus Batten-1
PRESS RELEASE

published on 09/26/2024 at 18:00, 1 year 4 months ago

THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2024
Theranexus, société biopharmaceutique, annonce ses résultats semestriels 2024. Baisse significative des charges d'exploitation grâce à la fin d'essais cliniques et efforts de réduction des coûts

Résultats Semestriels Biopharmaceutique Réduction Des Coûts Theranexus Maladies Neurologiques
PRESS RELEASE

published on 09/26/2024 at 18:00, 1 year 4 months ago

THERANEXUS ANNOUNCES FIRST HALF 2024 FINANCIAL RESULTS
Theranexus reports cost reduction success and positive first half 2024 financial results, led by completion of Batten-1 clinical trial and operating grants

Financial Results Cost Reduction Clinical Trial Theranexus Batten-1
BRIEF

published on 07/11/2024 at 18:50, 1 year 6 months ago

Theranexus annonce sa trésorerie au 30 juin 2024 et détaille le progrès de Batten-1

Financement Trésorerie Theranexus Batten-1 Maladie Neurologique
BRIEF

published on 07/11/2024 at 18:50, 1 year 6 months ago

Theranexus announces its cash flow as of June 30, 2024 and details the progress of Batten-1

Treasury Funding Theranexus Batten-1 Neurological Disease
PRESS RELEASE

published on 07/11/2024 at 18:45, 1 year 6 months ago

Theranexus publie sa trésorerie au 30 juin 2024 et fait le point sur l'avancement de Batten-1
Theranexus publie sa trésorerie au 30 juin 2024, avance sur Batten-1 et ouvre nouvelle ligne de financement en fonds propres. Commercialisation phase 3 Batten-1 en vue

Financement Trésorerie Fonds Propres Theranexus Batten-1
PRESS RELEASE

published on 07/11/2024 at 18:45, 1 year 6 months ago

Theranexus publishes its cash position as of 30 June 2024 and presents an update on the progress of Batten-1
Biopharmaceutical company Theranexus announces implementation of new equity line to finance Phase III trial for Batten-1 drug in juvenile Batten disease. Update on Batten-1 program included

Biopharmaceutical Company Phase III Trial Theranexus Batten-1 Equity Line
BRIEF

published on 07/03/2024 at 07:35, 1 year 6 months ago

Theranexus, CRNL et CERMEP lauréats du projet "Pacte de recherche 2024" d'Auvergne-Rhône-Alpes

Recherche Auvergne-Rhône-Alpes Theranexus Neurologie Neuroimagerie
BRIEF

published on 07/03/2024 at 07:35, 1 year 6 months ago

Theranexus, CRNL and CERMEP winners of the Auvergne-Rhône-Alpes “Research Pact 2024” project

Research Neurology Auvergne-Rhône-Alpes Theranexus Neuroimaging

Published on 01/31/2026 at 03:15, 1 day 6 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 7 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 8 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 9 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 10 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 18 hours 2 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 21 hours 32 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 7 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 11 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 13 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 15 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 15 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 16 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 16 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 1 hour ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News